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Abstract
Objectives: Single lung transplantation is a viable option for patients with end-stage pulmonary disease; despite encouraging results, we
observed serious complications arising in the native lung. We retrospectively reviewed 36 single lung transplants to evaluate the incidence of
complications arising in the native lung, their treatment and outcome. Methods: Between 1991 and 1997, 35 patients received 36 single lung
transplants for emphysema (16), pulmonary ®brosis (14), lymphangioleiomyomatosis (4), primary pulmonary hypertension (1) and bronch-
iolitis obliterans (1). The clinical records were reviewed and the complications related to the native lung were divided into early (up to 6
weeks after the transplant) and late complications. Results: Nineteen complications occurred in 18 patients (50%), leading to death in nine
(25%). Early complications (within 6 weeks from the transplant) were bacterial pneumonia (1), overin¯ation (3), retention of secretions with
bronchial obstruction and atelectasis (1), hemothorax (1), pneumothorax (1) and invasive aspergillosis (3); one patient showed active
tuberculosis at the time of transplantation. Two patients developed bacterial pneumonia and invasive aspergillosis leading to sepsis and
death. The other complications were treated with separate lung ventilation (1), bronchoscopic clearance (1), chest tube drainage (1) and
wedge resection and pleurodesis (mechanical) by VATS (1). One patient with hyperin¯ation of the native lung eventually required
pneumonectomy and died of sepsis. The patient with active tuberculosis is alive and well after 9 months of medical treatment. Late
complications were recurrent pneumothorax (4), progressive overin¯ation with functional deterioration (2), aspergillosis (1) and pulmonary
nocardiosis (1). Recurrent pneumothorax was treated with chest tube drainage alone (1), thoracoscopic wedge resection and/or pleurodesis
(2) and pneumonectomy (1); hyperin¯ation was treated with thoracoscopic lung volume reduction in both cases; both patients with late
infectious complications died. Conclusions: After single lung transplantation, the native lung can be the source of serious problems. Early
and late infectious complications generally result in a fatal outcome; the other complications can be successfully treated in most cases, even if
surgery is required. q 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Lung transplantation is a viable option for patients with
end-stage pulmonary parenchymal and vascular diseases.
Single lung transplantation (SLT) is considered the ideal
procedure for patients over the age of 50 years affected by
respiratory failure without septic lung disease [1]. Pulmon-
ary ®brosis (idiopathic and secondary to other conditions),
emphysema (in older patients without bullae), primary
pulmonary hypertension and Eisenmenger's Syndrome
(according to the policy of each institution) are the most
frequent indications; other more rare disorders like
lymphangioleiomyomatosis (LAM) [2] represent an indica-
tion in selected cases. SLT allows an ef®cient use of a
limited supply of donor organs yielding a satisfactory
pulmonary function with a relatively reduced surgical
trauma; for this reason it has been increasingly used despite
the potential disadvantage of a diseased native lung in place.
However, even if the results are encouraging with a 3-year
survival of 50±60% [3], serious complications may still
occur. The native lung could be the source of early and
late problems related to the progression of the underlying
disease and its ensuing complications. The susceptibility of
the native lung to develop complications may affect the
outcome of the transplant; this is an additional factor to be
considered when choosing the appropriate procedure for
each patient.
We retrospectively reviewed a combined series of SLT
performed at two institutions in order to evaluate the inci-
European Journal of Cardio-thoracic Surgery 16 (1999) 54±58
1010-7940/99/$ - see front matter q 1999 Elsevier Science B.V. All rights reserved.
PII: S1010-7940(99)00141-4
q Presented at the 12th Annual Meeting of the European Association for
Cardio-thoracic Surgery, Brussels, Belgium, September 20±23, 1998.
* Corresponding author. Tel.: 1 39-6-4461971; fax: 1 39-6-49970735.
E-mail address: fevenuta@tin.it (F. Venuta)
dence of complications arising in the native lung and their
outcome.
2. Methods
Between 1991 and 1997, 35 patients (nine males and 26
females; mean age: 36 years; range between 14 and 56
years) received 36 single lung transplants (23 right and 13
left) at two different institutions. All patients had end-stage
lung disease requiring supplemental oxygen and ful®lled the
standard criteria for inclusion in the waiting list for lung
transplantation. The indications were emphysema (44.4%),
idiopathic pulmonary ®brosis (36.1%), lymphangioleio-
myomatosis (11%), ®brosis secondary to chemo-radiother-
apy for Hodgkin's disease (2.8%), primary pulmonary
hypertension (2.8%) and obliterative bronchiolitis (2.8%).
Preoperative work-up included clinical evaluation, sputum
examination, ®beroptic bronchoscopy with bronchoalveolar
lavage in selected cases and CT scan to exclude any source
of potential infectious complications contraindicating SLT.
All the charts were retrospectively reviewed with particular
attention to preoperative conditions favouring the onset of
possible complications in the native lung (stable infectious
colonization, presence of blebs or bullae, history of pneu-
mothorax, diabetes mellitus and steroid administration). The
protocol of immunosuppression included ALG (for induc-
tion), cyclosporin, azathioprine and prednisone (starting
with 0.5±1 mg/kg per day and tapered to 0.1±0.2 mg/kg
per day after 6±8 months). Postoperative follow-up included
sequential radiological, functional and bronchoscopic work-
up at predetermined intervals (at least after 1, 3, 6 and 12
months), or when required. All the complications and their
outcomes were recorded with speci®c reference to any
problem coming from the native lung. Early (within 6
weeks from operation) and late complications were
reviewed separately. Particular attention was given to the
type and number of treatments required (medical treatment,
thoracoscopic procedures, surgical treatment). Survival was
calculated according to the Kaplan±Meier method [4]. The
Wilcoxon test was used to compare survival curves.
3. Results
The native lung was a source of 19 signi®cant complica-
tions occurring in the native lung in 18 patients (50%) lead-
ing to death in nine cases. Early complications were present
in 11 cases (Table 1): bacterial pneumonia (9.1%), overin-
¯ation of the native lung after SLT for emphysema (27.3%),
retention of secretions with bronchial obstruction and
atelectasis (9.1%), hemothorax (9.1%), pneumothorax
(9.1%) (Fig. 1) and invasive aspergillosis (27.3%); one
patient was found to have active tuberculosis (9.1%) at
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Table 1
Early complications arising in the native lung after single lung transplantation. COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary
®brosis; LAM, lymphangioleiomyomatosis; PPH, primary pulmonary hypertension; TB, Tuberculosis, P.O., postoperatively; CMV, Cytomegalovirus; MOF,
multiple organ failure; VATS, video assisted thoracoscopic surgery.
Diagnosis Age Complications Time of onset Therapy Outcome Cause of death
COPD 51 Pneumothorax 2nd day VATS Alive (5 years)
LAM 48 Invasive aspergillosis 4th week Medical/pneumonectomy Death (1 month) Fungal sepsis
IPF 54 Invasive aspergillosis 6th week Medical Death (1 month) Fungal sepsis/CMV
COPD 44 Overin¯ation Immediate P.O. Observation Alive (4 years)
IPF 47 Invasive aspergillosis 1 week Medical Death (1 month) Fungal sepsis
COPD 56 Overin¯ation/pneumothorax 2nd day Pneumonectomy Death (1 month) Sepsis
PPH 51 TB Immediate P.O. Medical Alive (5 years)
IPF 38 Pneumonia 2 weeks Medical Death (1 month) Sepsis/CMV
COPD 44 Secretion retention 2±3weeks Repeated FOB Alive (5 years)
IPF 33 Hemothorax 2 weeks Chest drainage Alive (2 years)
COPD 52 Overin¯ation 2±3 days Separate lung ventilation Death (2 months) Infection/MOF
Fig. 1. Left pneumothorax after right single lung transplantation for
emphysema.
the time of transplantation diagnosed in the explanted lung.
Infectious complications were thus present in ®ve cases; two
of these patients died within 2 months from bacterial pneu-
monia (due to Kiebsiella pneumoniae) and invasive
pulmonary aspergillosis. None of these patients presented
either bronchiectasis or preoperative colonization by the
agent causing the infectious complication or other resistant
strains. None of the patients had diabetes before the trans-
plant or assumed steroids at doses higher than 0.2 mg/kg per
day; one patient developed diabetes after the operation. The
immunosuppressive protocol was the same for all patients.
Fungal infections were not related to intensive care unit
outbreak. The non-infectious complications (6) were treated
with separate lung ventilation (n  1), repeated airway
cleaning with the ®beroptic bronchoscope (n  1), chest
tube drainage (n  1) and video-assisted thoracoscopic
wedge resection and pleurodesis (mechanical) (n  1).
One patient with persistent hyperin¯ation underwent pneu-
monectomy and died of sepsis 2 months later. None of the
patients developing early overin¯ation had bullae in the
native lung. The patient found to have active tuberculosis
at the time of transplantation received medical treatment for
9 months (Myambutol, Rifampicin and INH) and is alive
and well 5 years after the transplant.
Late complications (Table 2) were recurrent pneu-
mothorax (n  4), progressive overin¯ation with functional
deterioration after SLT for emphysema (n  2), aspergillo-
sis (n  1) (Fig. 2) and pulmonary nocardiosis (n  1) (Fig.
3). Recurrent pneumothorax occurred after a mean of 21
months (range 12±24 months) from the operation and was
treated with chest tube drainage in one patient and thoraco-
scopic wedge resection and pleurodesis (talc and mechan-
ical) in two cases; in one patient pneumonectomy was
performed after a previous attempt to solve the problem
with minimally invasive procedures; the patient is alive
and well. Hyperin¯ation of the native lung with functional
deterioration and dislocation of the mediastinum and hemi-
diaphragm occurred in two patients, respectively 2 and 3
years after the transplant. The possible role of the trans-
planted lung in the functional derangement was extensively
investigated [5] and obliterative bronchiolitis was excluded
with repeated trans-bronchial lung biopsies. Hyperin¯ation
was successfully treated with thoracoscopic lung volume
reduction and both patients are alive and well, respectively
2 and 5 years after the procedure. The two patients with late
infectious complications (one patient developed insulin
dependent diabetes after transplantation) died; one patient
with pulmonary nocardiosis presented a systemic spread of
the disease and died of sepsis 2 years after transplantation;
one patient developed systemic aspergillosis and died 14
months after the transplant. Two-year survival for patients
with early complications and patients without complications
in the native lung is shown in Fig. 4 (P  0:04). Three-year
survival for patients with late complications was 75%.
4. Discussion
Single lung transplantation (SLT) offers an effective
option for the treatment of several pulmonary diseases [6±
8]. Generally, the indications for SLT and DLT overlap in
patients without septic disorders and aged less than 45±50
years. The limitation of suitable donors requires a better use
of the resources, and splitting of the double lung block
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Table 2
Late complications arising in the native lung after single lung transplantation. LAM, lymphangioleiomyomatosis; IPF, idiopathic pulmonary ®brosis; COPD,
chronic obstructive pulmonary disease; PF, pulmonary ®brosis; VATS, video assisted thoracoscopic surgery; LVRS, lung volume reduction surgery; OB,
obliterative bronchiolitis.
Diagnosis Age Complications Time of onset Therapy Outcome Cause of death
LAM 36 Pneumothorax 2 years Chest Tube Alive (5 years)
LAM 33 Pneumothorax 2 years VATS Alive (3 years)
IPF 46 Pneumothorax 2 years Pneumonectomy Alive (3 years)
COPD 56 Overin¯ation 2 years VATS-LVRS Alive (3 years)
IPF 42 Pneumothorax 2 years VATS Death (7 years) OB
COPD 44 Overin¯ation 3 years VATS-LVRS Alive (5 years)
COPD 56 Invasive Aspergillosis 13 months Medical Death (14 months) Fungal sepsis
PF POST CHEMO 14 Nocardia 2 years Medical Death (2 years) Fungal sepsis
Fig. 2. Pulmonary aspergillosis in the native lung after right single lung
transplantation for emphysema.
between two recipients (twinning procedure) [9] has
become an effective approach to improve organ sharing.
However, after SLT, the contralateral native lung remains
a potential source of complications that may impair both
early and late outcome [10±13]. For this reason, the impact
of the remaining lung on morbidity and mortality following
SLT may affect the choice of the type of transplant, espe-
cially in patients in whom either SLT and DLT can be
performed.
Most of the previous reports emphasize the incidence of
ventilation/perfusion (V/Q) mismatch, early and late hyper-
in¯ation and even sepsis after SLT for emphysema
[5,12,14]; early hyperin¯ation and V/Q mismatch may be
a dreadful complication; it can be prevented by careful
selection of patients and donors: patients with bullous
disease and repeated infections due to bacterial colonization
should be excluded from SLT. Patients with extremely
severe preoperative airway obstruction, air trapping and
relative pulmonary hypertension seem to be at the greatest
risk of developing hyperin¯ation [15]; however, in our
series, none of the patients developing this complication
showed these preoperative risk factors. The use of marginal
donors should be avoided; in fact, a well functioning trans-
planted lung, larger than the predicted total lung capacity of
the recipient, can prevent severe hyperin¯ation of the native
lung. Right SLT for emphysema should be preferred, since
the mild hyperin¯ation of the native lung easily displaces
the left hemidiaphragm downward, without mediastinal
shifting.
Late hyperin¯ation of the native lung requires different
considerations; it may be related to the decreased compli-
ance of the graft (obliterative bronchiolitis ± BOS, infection,
rejection) or to the progression of the underlying chronic
obstructive pulmonary disease in the native lung itself.
Infectious complications should be excluded and the possi-
ble development of obliterative bronchiolitis should be
ruled out. In the absence of histologic con®rmation, the
diagnosis of BOS should be presumed. If augmented immu-
nosuppression does not result in functional improvement
and hyperin¯ation of the native lung persists, the latter
could play a role in the development of dyspnoea. However,
preoperative work-up may not allow a precise assessment of
the amount of dysfunction related to the progressive
compression of the graft by the native lung and the possible
coexistence of BOS. If marked functional improvement
follows unilateral volume reduction, the diagnosis of BOS
may be left out. When hyperin¯ation is related to the
presence of large bullae, bullectomy is well established to
relieve compression [16]. More recently, attention has been
focused on the potential bene®ts of surgical resection of
areas of diffusely emphysematous lung parenchyma to
reduce hyperin¯ation and improve dyspnoea [17,18].
Bullectomy and unilateral volume reduction surgery of the
native lung after SLT for emphysema have been reported
[5,19,20]; both thoracotomy and thoracoscopy were
performed and the results were satisfactory with both
approaches.
The underlying lung disease in the native lung often
predisposes to pneumothorax (e.g. in patients with emphy-
sema, pulmonary ®brosis and LAM). Mechanical ventila-
tion in the early postoperative period may favour its onset;
however, pneumothorax may also present later, even several
years after the transplant, in line with the natural history of
the underlying disease. Thoracoscopic pleurodesis is the
therapeutic gold standard and results are satisfactory in
most of the cases [12,21].
Infectious complications in the native lung [11,22,23]
often result in a fatal outcome. Despite sputum examination
and ®beroptic bronchoscopy during preoperative work-up in
selected cases, infectious complications in the native lung
are not uncommon. The persistence of bacterial coloniza-
tion even after appropriate medical treatment may support
the indication for double lung transplantation, especially in
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Fig. 3. Nocardia arising in the native lung after left single lung transplanta-
tion for pulmonary ®brosis.
Fig. 4. Survival of patients with early complications arising in the native
lung and patients without complications (P  0:04).
patients with pulmonary ®brosis. This careful assessment is
intended to reduce the chance of infectious complications
arising in the native lung and spreading to the graft after the
onset of immunosuppression. None of our patients
presented infectious problems at preoperative evaluation;
however, 75% of patients presenting early infectious
complications (bacterial and fungal) had pulmonary ®brosis
and received azathioprine and steroids for a long time before
the operation and this may have contributed to the increased
incidence of this complication. Radiological evaluation of
the native lung may be dif®cult: patients with pulmonary
®brosis show an increased density of the native lung on
chest x-ray, and early diagnosis of pneumonia may be dif®-
cult or even impossible. Computed tomography is manda-
tory for con®rmation in suspected cases. In our experience,
diffuse spreading of the infection was always fatal. The
predisposition to infections and their early spreading may
be due to the decreased mucociliary clearance, altered
sputum characteristics and, at times, chronic bacterial colo-
nization [22] and diabetes.
Postmortem ®ndings [24] after SLT showed the presence
of a signi®cant number of pathologic conditions, in addition
to the native disease. Most of these ®ndings are related to
infectious complications, but also lymphoproliferative
disorders and lung cancer have been described, probably
in relation to the smoking history of the patient. We recog-
nize that our incidence of complications arising in the native
lung is higher than that reported by other groups; this may
be in part related to the fact that most of these complications
occurred in the early period of our lung transplantation
program. In recent times, DLT have been performed more
often in our lung transplant program to reduce the incidence
of problems related to the native lung both in the early and
late course after the operation.
In conclusion, after single lung transplantation, the native
contralateral lung may be the source of serious problems.
Infectious complications often resulted in a fatal outcome,
despite appropriate medical treatment. Non-infectious
complications were successfully treated in most of the
cases, also when required a surgical approach. Double
lung transplantation should be considered more often, espe-
cially for young patients, in order to decrease the rate of
complications arising in the native lung and improve func-
tional outcome, in particular when BOS occurs.
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